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Abstract:  Retroviruses have been detected in most vertebrate species and are etiologic 
agents of a variety of neoplastic diseases. The study of retroviruses has been instrumental 
in uncovering the molecular mechanisms responsible for oncogenesis. Retroviruses have 
been isolated from three neoplastic diseases in fish, two of which affect the dermis and 
regress naturally coincident with spawning. This feature provides a unique model to study 
mechanisms of tumor development and regression. Three complex retroviruses, isolated 
from walleye (Sander vitreus) with dermal sarcoma and epidermal hyperplasia, are the 
members  of  the  newest  retroviral  genus,  Epsilonretrovirus.  Three  accessory  proteins, 
encoded by walleye dermal sarcoma virus (WDSV), function in the regulation of host and 
viral  gene  expression  and  cell  cycle,  alter  cell-signaling  pathways  to  promote  cell 
proliferation and block apoptosis, and, finally, induce apoptosis through dissipation of the 
mitochondrial membrane potential. 
Keywords: retrovirus; epsilonretrovirus; oncogenesis; walleye dermal sarcoma virus; fish; 
retroviral cyclin; RACK1; apoptosis; mitochondria  
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1. Introduction  
The identification of retroviruses as etiologic agents of a variety of neoplasms began in the early 
20th century. The study of these viruses has been instrumental in uncovering molecular mechanisms of 
tumor  development.  Exogenous  retroviruses  have  been  isolated  from  many  vertebrates  and  are 
classified into two subfamilies, Orthoretrovirinae and Spumaretrovirinae. The Orthoretrovirinae are 
further  broken  down  to  six  genera,  Alpharetrovirus,  Betaretrovirus,  Gammaretrovirus, 
Deltaretrovirus, Epsilonretrovirus, and Lentivirus, based largely on highly conserved regions within 
the  reverse  transcriptase  or  “pol”  gene.  The  most  recent  genus  added  to  the  Retroviridae  is  the 
Epsilonretroviruses, which includes three fish retroviruses: walleye dermal sarcoma virus (WDSV) 
and  walleye  epidermal  hyperplasia  viruses  type  1  and  type  2  (WEHV-1,  WEHV-2 
(www.ICTVonline.org).  Two  additional  viruses,  perch  epidermal  hyperplasia  virus  types  1  and  2 
(PEHV-1, PEHV-2), are likely members, but their sequence is incomplete [1]. The exogenous piscine 
retroviruses, snakehead retrovirus (SnRV) and salmon swimbladder sarcoma-associated virus (SSSV), 
have not yet been assigned to a specific genus.  
Exposure  to  chemical  carcinogens  and  infection  by  herpesviruses  has  also  been  implicated  in 
proliferative diseases of fish. The specific association of retroviral infection with proliferative lesions 
in  fish  is  based  on  the  presence  of  retrovirus-like  particles  and  reverse  transcriptase  activity  in 
neoplastic tissue [2]. To date, the complete sequence of five exogenous retroviruses, four of which are 
associated with neoplastic diseases in fish, have been determined [3-7]. SSSV was first identified in 
Atlantic salmon (Salmo salar) in 1976 from a commercial fish farm and is associated with neoplasia of 
the swimbladder [8,9]. The SnRV was isolated from cell culture and any association with disease is 
currently unknown [10]. This review will focus on walleye retroviruses and their associated neoplastic 
diseases with an emphasis on walleye dermal sarcoma virus. 
2. Epsilonretroviruses and associated diseases 
2.1. Disease, pathology and transmission  
Retroviruses  from  two  proliferative  skin  lesions  in  walleye  (Sander  vitreus),  walleye  dermal 
sarcoma (WDS) and walleye epidermal hyperplasia (WEV), have been isolated and their sequence 
determined [3,5,6,11-13]. These proliferative diseases were first reported by Walker in 1969 in walleye 
collected from Oneida Lake in New York State and have been reported to occur elsewhere in North 
America [14-16]. Upwards of 27% of walleye are affected with WDS and 10% with WEH annually in 
Oneida Lake [14,16-18]. The most interesting and defining feature of these proliferative diseases is 
their seasonal cycle [19]. The highest incidence of disease occurs throughout the late fall until the 
spring spawning period at which time the lesions naturally regress. During the summer months, lesions 
are very rarely observed [20].  
WEH lesions are broad, flat, translucent plaques of thickened epidermis that range in size from 2 to 
3 mm up to 50 mm in diameter. Histologically, WEH consists of localized hyperplasia of Malpighian 
cells with frequent mitotic figures [14-16]. 
WDS are cutaneous mesenchymal neoplasms that are randomly distributed on the fish, arise from 
the  superficial  surface  of  the  scales  and  range  in  size  from  0.2-1.0  cm  in  diameter  (Figure  1)  Viruses 2010, 2                         
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[14-16,21]. Multiple tumors often coalesce. Histologically, the tumors are non-encapsulated nodular 
masses consisting of interwoven bundles and whorls of fibroblast cells that abut the epidermis. Mitotic 
figures  are  rare  and  the  overlaying  epidermis  is  often  ulcerated  in  the  regressing  tumors  [21]. 
Perivascular accumulation of lymphocytes and aggregates of inflammatory cells within the dermis 
surrounding the mass have been observed in some tumors [2,21,22]. Tumors have not been observed in 
internal organs [21,23]. Rare cases of invasive WDS have been documented in adult wild fish where 
the tumor tissue invaded below the dermis into the muscle and bone of the operculum [24].  
The observation of type C retroviral particles in tumors by electron microscopy provided the first 
evidence  for  retroviral  infection  associated  with  proliferative  lesions  in  walleye  [14,18].  To 
demonstrate  a  viral  etiology  for  walleye  dermal  sarcoma,  12-week  old  walleye  fingerlings  were 
inoculated  with  cell-free  material  prepared  from  regressing  tumors  collected  during  the  spring 
spawning run [25]. Transmission of disease is very efficient: Within 14 weeks post infection, 87% of 
experimentally infected fish developed tumors that were grossly and histologically identical to those 
observed on naturally affected adult walleyes (Figure 1) [25]. Experimental transmission of disease is 
successful with intramuscular injection, oral gavage or topical application of infectious material [26]. 
A  fundamental  finding  from  transmission  studies  was  the  inability  of  homogenates  of  developing 
tumors to transmit disease. These tumors were collected from fish in the late fall, and the lack of 
transmission is due to the absence of infectious virus [27].  
Locally invasive tumors were observed in experimental transmission studies and their incidence 
was correlated with the age of fish at the time of infection [26,28]. All fish infected at 6-8 weeks of age 
developed invasive tumors whereas only 2% of fish infected at 12 weeks of age developed invasive 
tumors [26,28]. No fish infected at 52 weeks of age developed invasive tumors. Poor transmission of 
disease was observed with cell-free material from naturally occurring invasive tumors, which likely 
reflects  the  low  levels  of  infectious  virus  present  in  these  tumors  [24].  Dermal  sarcoma  is  also 
experimentally transmissible to sauger (Stizostedion canadense) and yellow perch (Perca flavescens) 
[29,30]. Transmission of WEH to walleye fingerlings has also been achieved with cell-free material 
from lesions collected in the spring [17].  
Figure 1. Experimental transmission of walleye dermal sarcoma with cell-free filtrate from 
regressing tumors. Left: Gross pathology of tumors. An individual tumor and a large mass 
of coalescing tumors are visible. Right: Histopathology of walleye dermal sarcoma. 
 
 
Based  on  the  observation  that  tumor  development  and  regression  is  seasonal  in  nature,  the 
experimental  transmission  model  of  WDSV  was  used  to  address  any  correlation  between  water 
temperature  and  tumor  regression.  Fish  were  infected  and  held  at  15  °C.  Five  months  after  the Viruses 2010, 2                         
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development of tumors, fish were randomly assigned to temperature treatment groups of 10 °C, 15 °C 
or 20 °C for an additional 5 months. Tumor regression occurred in 3% of fish held at 10 °C, 28% of 
fish held at 15 °C and 32% of fish held at 20 °C, suggesting that increases in water temperature may 
affect regression [31].  
Transmission  of  WDSV  in  nature  is  believed  to  occur  through  contact  with  water  containing 
infectious virus or by direct contact of walleye during the spring spawning run, a time when virus 
expression in tumors is plentiful and fish are congregating in high numbers [32]. Studies conducted at 
the Oneida Lake Fish Cultural Station from 1995 through 2003 on the prevalence of WDS in different 
age classes of walleye indicated that fish only develop tumors for one season and remain tumor-free in 
following years, implicating a role for an immune response in tumor regression [33]. The experimental 
transmission and regression model system was used to address this possibility. Fish previously infected 
with virus were rechallenged and monitored for the appearance of new tumors. The incidence of new 
tumors on these fish was significantly lower than that in naïve fish infected with the same inoculum 
[34]. These studies also indicated that most walleye will develop WDS in their lifetime after the age of 
sexual maturity and first participation in the spring spawning.  
2.2. Molecular characterization of Epsilonretroviruses. 
WDS  and  WEH  transmission  was  demonstrated  with  cell  free  tumor  homogenates  and  type  C 
retroviral particles have been observed in tumors [14,17,25]. Further characterization of these viruses 
was hindered by the lack of a cell culture system for virus propagation. Therefore, purified virus from 
tumors  was  utilized  in  the  initial  molecular  characterization  studies  [12,13].  Virus  particles  were 
purified from tumors by sucrose density gradient centrifugation [12,13]. Reverse transcriptase activity 
was detected in pooled fractions with a density of 1.18 gm/ml and electron microscopy was used to 
visualize viral particles. RNA was prepared from the sucrose banded virions and used for the synthesis 
of a cDNA hybridization probe [13].  
Figure 2. Organization of the WDSV genome. 
 
 
 
   
WDSV was originally cloned from regressing tumor DNA in 1990 and found to be 12.7 kb in 
length [12,13]. Sequence analysis identified, in addition to gag, pro, pol and env, three open reading 
frames,  designated  orf  a,  orf  b  and  orf  c,  that  encode  viral  accessory  proteins  (Figure  2)  [5].  A 
productively infected cell line, STEC, was established from a regressing tumor in 2003, approximately 
13 years after the harvest of the tumor used for the original WDSV sequence [3]. The sequence of 
WDSV present in the STEC cell line revealed a total of 27 point mutations over the entire genome 
(12,706  bp)  compared  to  the  previous  sequence.  Only  six  of  these  mutations  altered  amino  acid 
sequences: one in the amino terminus of RT, four in the surface domain (SU) of envelope, and one in 
the Orf B protein [3]. There were no variations in the LTR or upstream untranslated region of the 
genome. A significant sequence variation was identified in the transmembrane region (TM) of env: the 
b
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insertion  of  one  guanine  and  one  cytosine  residue  at  nt  9340  and  nt  9347,  respectively.  These 
insertions result in a frameshift and the generation of a stop codon at nt 9451 compared with the stop at 
nt 9649 in the original WDSV molecular clone. The result is an alteration of the 37 carboxy-terminal 
amino acids and shortening of the envelope protein TM by 63 amino acids (corrected env sequence 
GenBank accession no. EF428979) [3,5]. Resequencing of the original WDSV clone identified these 
same insertions indicating that they are not variations from the 1990 isolate. The revised envelope 
protein has at least two predicted membrane-spanning regions [3,35,36]. These transmembrane helices 
lie between amino acids (a.a.) 850 and 874 and a.a. 1045 and 1069 with an intervening cytoplasmic 
loop.  Budding  virus  was  observed  within  STECs  adjacent  to  internal  membranes  or  cisternae, 
including mitochondrial membranes, and approximately one half of the infectious virus produced by 
these  cells  remains  within  the  cell.  Examination  of  the  envelope  sequence  identified  a  consensus 
arginine-based endoplasmic reticulum (ER) localization signal, IRRER (a.a. 880-884), in the predicted 
cytoplasmic loop adjacent to the helix terminating at a.a. 874. This signal may serve to retain the 
envelope protein at internal membranes and cause the virus to bud internally in a manner similar to that 
of the spumaretroviruses, which use a KKXX motif for ER retention. Such a mechanism may be 
critical to the stability of infectious virus in an aquatic environment.  
The results of WDSV sequence analysis made possible investigations of virus expression in tumors. 
Of  particular  interest  is  the  quantitative  and  qualitative  differences  noted  in  the  extent  of  virus 
transcripts  and  viral  DNA  in  developing  and  regressing  tumors.  Developing  tumors  contain 
approximately one copy of viral DNA per cell, whereas cells of regressing tumors have 10-50 copies, 
most of which are unintegrated [3,5,12,27,37]. During the period of tumor growth, only the orf a and 
orf b subgenomic transcripts are expressed, whereas the spliced env transcript and full-length genomic 
RNA along with a variety of subgenomic spliced transcripts are expressed only in regressing tumors 
[12,27,37,38]. These results explain the inability to transmit disease with homogenates of developing 
tumors, due to the lack of expression of the viral genome, and implicate the products of orf a and orf b 
in tumor cell proliferation [27,38].  
The two retroviruses that are associated with walleye epidermal hyperplasia, WEHV-type 1 and 
WEHV-type 2 were cloned by RT-PCR using degenerate pol primers followed by 5ʹ and 3ʹ RACE and 
the generation of a lambda genomic library [39,40]. Sequence analysis determined that WEHV-1 and 
WEHV-2 are 13.0 and 13.1 kb in length and have the same genomic organization as WDSV [5,6]. All 
the walleye retroviruses utilize histidyl-tRNA as a primer for initiation of minus-strand synthesis. One 
to three copies per cell of integrated proviral DNA is found in epidermal hyperplasia lesions [11]. 
WEHV also exhibits temporal gene expression in lesions collected in the fall and spring, similar to that 
of WDSV. The function of the WEHV accessory gene proteins has not been extensively studied.  
Hyperplasia lesions similar to that described in walleye are also found on yellow perch in Oneida 
Lake  and  these  lesions  are  associated  with  two  new  retroviruses  tentatively  identified  as  perch 
epidermal hyperplasia virus types 1 and 2 [1,14]. Based on partial sequence, the perch hyperplasia 
viruses are distinct from the walleye viruses, but their genome organization is likely similar to them.  Viruses 2010, 2                         
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2.3. WDSV accessory protein function 
Immunofluorescence was used to visualize the expression and localization of the predicted WDSV 
accessory proteins in naturally infected tumor cells and in cell lines expressing recombinant proteins 
(Figure 3) [3,41-43].  
Figure  3.  Expression  of  WDSV  accessory  proteins  in  cells  derived  from  a  naturally 
occurring spring tumor. Cells were labeled with rabbit antisera reactive to the indicated 
WDSV proteins and FITC-conjugated goat anti-rabbit IgG (green). Nuclei were stained 
with DAPI (blue). Magnification x400. 
 
 
2.3.1. WDSV rv-cyclin 
The  WDSV  orf  a  transcript  is  one  of  two  multiply  spliced  transcripts  detected  during  tumor 
development, suggesting a role in tumor formation [27,38]. Sequence comparisons of the WDSV and 
WEHV Orf A proteins identified the presence of a cyclin box fold so it was named "retroviral cyclin" 
or “rv-cyclin” [44]. The rv-cyclin sequences do not have sufficient homology to host cyclins (less than 
20% linear sequence identity to any metazoan cyclin) to have resulted from a recent transduction of a 
cellular oncogene. The WDSV rv-cyclin is a 297 amino acid protein that, in addition to the cyclin box 
(a.a.  1-220),  also  contains  an  acidic  transcription  activation  domain  (a.a.  240-270)  with  a  TAF9 
binding motif (a.a. 257-266) in its extended C terminal region (Figure 4, left) [44-46]. In contrast, the 
shorter WEHV-1 and WEHV-2 rv-cyclins contain only the predicted cyclin box.  
Whether detected as native protein in naturally infected tumor cells (Figure 3) or over-expressed in 
a  variety  of  mammalian  and  piscine  cell  lines,  the  WDSV  rv-cyclin  is  primarily  localized  in  the 
nucleus and is concentrated in perichromatin fibrils and interchromatin granule clusters (IGCs; also 
known  as  nuclear  speckles)  (Figure  4,  right)  [3,43].  IGCs  are  defined  by  high  concentrations  of 
transcription and splicing factors, such as splicing component, SC35, and are at or near chromatin 
domains exhibiting high rates of transcription [47-52]. 
Rv-cyclin co-purifies and is co-precipitated with hyperphosphorylated forms of RNA polymerase II 
(RNA Pol II), p300, CBP, TATA-binding protein (TBP) and Mediator components [45,46,53]. The 
localization and physical association of rv-cyclin with components of transcription indicated a role in 
transcription regulation, a common function among complex retroviruses. Reporter assays of WDSV 
and SV40 promoters demonstrated that rv-cyclin may inhibit or enhance individual promoter activities 
in  a  cell-specific  manner  [45,53,54].  The  WDSV  rv-cyclin  inhibits  transcription  from  the  WDSV Viruses 2010, 2                         
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promoter. Experiments using a transiently transfected reporter system determined that this inhibition 
works with a minimal core promoter and is independent of specific sequences in the enhancer region 
[53]. The transcription activation domain (AD) of rv-cyclin was first identified in studies addressing 
the function of rv-cyclin in transcription regulation using GAL4 fusions of rv-cyclin [45]. Fusion of 
the  GAL4  DNA  binding  domain  to  rv-cyclin  or  to  the  isolated  AD  resulted  in  activation  of 
transcription from a GAL4 responsive luciferase reporter. Mutation V260S within the AD eliminated 
activation of transcription from the GAL4 luciferase reporter. Inhibition of the WDSV promoter is also 
dependent upon the rv-cyclin AD and the V260S mutation relieves this inhibition [45]. Zhang and 
Martineau [54] also demonstrated rv-cyclin inhibition of promoter activity, however, they attributed 
this effect to the first 49 amino acids. The WDSV rv-cyclin AD co-precipitates with p300/CBP and the 
Mediator component Med23 (Sur2) and directly binds to TATA binding protein-associated factor 9 
(TAF9) [46,53]. Binding of rv-cyclin to TAF9 is dependent upon amino acid V260 and binding was 
lost with a V260S mutation [46]. The conservative V260F mutation retains binding to TAF9 and 
function in reporter assays. The AD interferes physically and functionally with herpes simplex virus 
VP16-TAF9 contact and with the function of transcription factor, NF-κB, in transient transfection 
assays  with  an  NF-κB-specific  reporter  [46,55].  This  inhibition  was  found  to  be  the  result  of  the  
rv-cyclin  AD’s  ability  to  interfere  with  the  function  of  the  p65  activation  domain,  which  is  also 
dependent  upon  TAF9  binding.  Together  these  studies  indicate  that  the  AD  functions  in  both  the 
activation and inhibition of host and virus gene expression. The negative regulation of the WDSV 
promoter and of NF-κB-dependent promoters, such as the type I interferon promoter in fish, is likely 
advantageous  early  in  infection.  These  mechanisms  may  thwart  the  innate  immune  response  and 
maintain low levels of virus expression during tumor development in order to avoid humoral and cell-
mediated immune responses and the cytopathic effects associated with virus production.  
Figure 4. Model of rv-cyclin functional domains (Left) and localization in the nucleus in 
interchromatin granule clusters (Right). Cells were transfected with an rv-cyclin expression 
vector (pKH3-rv-cyclin) and stained with anti-rv-cyclin antisera and FITC-conjugated goat 
anti-rabbit IgG (green). Nuclei were stained with DAPI (blue). Magnification x400.  
 
 
The cyclin box fold is a protein-binding domain common to cyclins, TFIIB, and Retinoblastoma 
protein (pRb). Each contains two copies of the domain, which is characterized by a similar alpha-
helical  structure,  but  with  remote  linear  sequence  identity  [56].  Alignments  of  the  rv-cyclin  with 
cyclins A, C, and D have been proposed based on combinations of sequence identity and proposed Viruses 2010, 2                         
 
 
1991
function  [44,53,57].  The  presence  of  the  cyclin  box  fold  suggests  an  interaction  with  a  cyclin-
dependent kinase (cdk), and a screen for such an interaction demonstrated an association of rv-cyclin 
with cdk8 [53]. Cdk8 and its partner, cyclin C are components, with Med12 and Med13, of the "cdk8 
module" of the Mediator complex, which functions as a modifier of transcription. They are also highly 
conserved with 96% and 94% sequence identity between human and zebrafish cdk8 and cyclin C, 
respectively. Recent studies demonstrate a direct interaction of rv-cyclin with cdk8 by co-IP, GST pull 
down, and between purified, recombinant rv-cyclin and cdk8 [58]. The binding of the rv-cyclin to cdk8 
does not appear to alter cdk8 substrate specificity, but does alter its nuclear localization, resulting in a 
tight association of a significant portion of the cdk8 pool with chromatin. Cdk8 is a positive regulator 
of transcription at chromatin via phosphorylation of serine 10 of histone 3, of transcription factor 
E2F1, and of serine 5 of the heptad repeat in the carboxy terminal domain of RNA Pol II, which 
increases the processivity of transcription elongation [59-61]. 
Cyclin C also partners with cdk3, an interaction that promotes phosphorylation of pRb to initiate 
G0/G1 transition and exit of quiescent cells from G0 [62]. Based on these observations an interaction 
of WDSV rv-cyclin with cdk3 was evaluated and it was found that rv-cyclin also interacts directly with 
cdk3  and  activates  cdk3  phosphorylation  of  pRb  [58].  Using  yeast  (Saccharomyces  cerevisiae) 
conditionally deficient in G1 cyclins (Cln genes) LaPierre et al. [44] demonstrated that WDSV rv-
cyclin, but not WEHV rv-cyclins, restored cell growth. The interaction of WDSV rv-cyclin with cdk3 
would explain the results of these studies. Cyclin C was first identified in complementation assays 
using  yeast  deficient  in  Cln  genes  [63-65].  Combined,  these  data  suggest  that  WDSV  rv-cyclin 
functions as an ortholog of cyclin C. 
Identification of rv-cyclin as a structural and functional ortholog of a cellular cyclin, suggests a role 
in  tumor  development.  In  transgenic  mice,  expression  of  rv-cyclin  from  a  keratin  promoter  was 
associated with severe squamous cell hyperplasia and dysplasia at sites of injury such as tail clipping 
[66].  In  contrast,  transgenic  expression  of  WDSV  rv-cyclin  in  zebrafish  did  not  result  in  tissue 
proliferation even following tissue regeneration after fin clipping [67]. No increase in tumor incidence 
was seen in rv-cyclin transgenic fish exposed to N-ethyl N-nitrosourea (ENU), a chemical carcinogen, 
over that observed in control transgenic fish treated with ENU [67]. In a second study of rv-cyclin 
transgenic zebrafish in which rv-cyclin was expressed in the liver, no apparent tumors developed [68]. 
Treatment of fish with the chemical carcinogen 7,12-dimethylbenz [α] anthracene (DMBA) resulted in 
the development of liver tumors in 45% of rv-cyclin negative fish and 51% of the rv-cyclin transgenic 
fish [68]. Based on histopathology, the rv-cyclin negative fish had a higher incidence of malignant 
liver neoplasia than the rv-cyclin transgenic fish. Additionally, the time to development of tumor, after 
exposure to DMBA, was increased in rv-cyclin transgenic fish. Zhan et al. [65] suggest that rv-cyclin 
suppresses the development of liver tumors after chemical carcinogen exposure.  
2.3.2. WDSV Orf B. 
The WDSV Orf B protein, like rv-cyclin, is expressed during tumor development. WDSV Orf B 
localizes to the plasma membrane in structures consistent with focal adhesions and lamellapodia, and 
is found associated with actin stress fibers (Figure 3) [3,41]. WDSV Orf B directly interacts with the 
Receptor for Activated Kinase C (RACK1), a highly conserved adaptor protein that binds to activated, Viruses 2010, 2                         
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conventional isoforms of protein kinase C (PKC) [41]. The amino acid sequence of walleye RACK1 is 
96% identical to human and mouse RACK1. RACK1 functions as an anchoring protein to stabilize 
PKC in an active conformation at the cell membrane [69,70]. PKC regulates signaling pathways that 
mediate cell proliferation and survival. In NIH-3T3 cells that stably express Orf B (NIH-3T3-Orf B), 
Orf B is found in a complex with PKCα [41]. Activated PKCα was only translocated to membranes 
after treatment of NIH-3T3 cells with PMA.   In contrast, activated PKCα was present in membrane 
fractions  from  NIH-3T3-Orf  B  cells  cultured  without  serum  and  without  PMA  stimulation. When 
cultured without serum, NIH-3T3-Orf B cells were able to proliferate. However, in the presence of the 
PKC  inhibitor,  bisindolymaleimide  hydrochloride,  the  growth  of  these  cells  was  significantly 
diminished [41]. Treatment of NIH-3T3-Orf B cells with concentrations of staurosporine known to 
induce apoptosis did not cause death of these cells, and in a screen to identify downstream targets of 
activated PKC, the pro-apoptotic protein, BAD, was found to be inactivated by phosphorylation at 
residues 112, 136 and 155, substrates of activated PKC and AKT signaling pathways [71]. Further 
studies showed that AKT is activated in NIH-3T3-Orf B cells, and that this activation also contributes 
to cell survival and functions to elicit a transformed phenotype [71]. Overall, these studies indicate that 
expression of Orf B leads to the activation of PKC and AKT signaling pathways and has the capacity 
to transform cells in vitro.  
2.3.3. WDSV Orf C. 
The third novel accessory protein of WDSV, Orf C, is encoded by an open reading frame that lies 5ʹ 
proximal to gag (Figure 2) [5]. After the end of the orf c reading frame there are seven base pairs prior 
to the initiation of the gag/pro/pol polyprotein. No specific Orf C transcript has been identified, so the 
protein is presumed to be translated from the full-length WDSV genomic mRNA, which is present at 
high levels during tumor regression [38]. The Orf C protein is present in regressing tumors and can be 
detected  by  western  blot  and  in  regressing  tumor  sections  and  in  tumor  explant  cells  by 
immunofluorescence (Figure 3) [3,42]. The specific cytoplasmic localization of Orf C in mitochondria 
was identified in cells transiently transfected with an Orf C expression plasmid (Figure 5) [42]. The co-
localization  of  Orf  C  with  cytochrome  c  in  mitochondria  was  associated  with  their  perinuclear 
clustering and loss of mitochondrial membrane potential, which was confirmed by the inability of Orf 
C-positive mitochondria to retain the vital dye, Mitotracker. The mechanism of localization of the Orf 
C protein was predicted to be dependent upon an amphipathic alpha helix at position 78 to 89 [72], but 
efforts to knockout this mitochondrial targeting motif have been unsuccessful [73]. 
The outcome of the over-expression of Orf C in piscine and mammalian cells is the induction of 
apoptosis  [42].  The  role  of  apoptosis  in  tumor  regression  was  demonstrated  by  terminal 
deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) of sections of regressing tumors 
(Figure 6). This assay detected a significant number of apoptotic nuclei (brown precipitate) in a typical 
regressing tumor. These data suggest a direct role for the Orf C protein as an oncolytic protein and 
indicate that tumor regression, like the tumorigenic process, may be largely  controlled by WDSV 
accessory proteins. Furthermore, both processes—the formation and growth of the tumor mass and its 
regression  and  shedding  from  the  host—are  integral  to  successful  WDSV  replication  and 
dissemination.  Viruses 2010, 2                         
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Figure 5. WDSV Orf C localizes to the mitochondria. Cells transfected with HA-tagged 
Orf C expression vector were stained with rabbit anti-HA antisera and a mouse monoclonal 
antibody  that  recognizes  cytochrome  c  followed  by  staining  with  anti-rabbit  IgG-FITC 
(green) or anti-mouse IgG-rhodamine (red). An overlay image of the staining is presented 
in the right panel.  Nuclei were stained with DAPI (blue).    
 
 
Figure  6.  TUNEL  staining  of  regressing  dermal  sarcoma.  HRP  mediated  3,3’-
Diaminobenzidine  (DAB)  deposition  (brown)  in  nuclei  after  biotin-dUTP  labeling  of 
chromosomal DNA strand breaks. 
 
 
3. Conclusions 
WDSV is exceptional among tumor virus models in that it has incorporated tumorigenesis and 
tumor regression into its life cycle and coordinates these processes with the seasonal spawning of 
walleye. After infection with WDSV there is a period of restricted virus expression, associated with 
tumor progression followed by a switch to overt virus production and tumor regression. The fully 
developed sarcoma with its high levels of cell-associated virus serves as a vessel for virus transmission 
in that the tumor mass is shed into the surrounding water during a period of maximum fish-to-fish 
contact. This final step serves in the efficient transmission of virus to naïve animals in an aquatic 
environment. Epidemiology studies suggest that the process occurs once in the lifetime of the host 
indicating that fish are resistant to development of tumors in subsequent years. 
The functions of the WDSV rv-cyclin and Orf B proteins in this process appear to be twofold: 
constrain virus replication and drive tumor formation. Clear evidence exists for down regulation of the 
WDSV promoter by rv-cyclin. This protein also has the capacity to play a direct role in transformation Viruses 2010, 2                         
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by regulation of host gene transcription and promotion of the entry of quiescent cells into cycle via 
cdk3 activation. The rv-cyclin may also interfere with innate immune mechanisms by blocking NF-κB 
and interferon transcription. Orf B protects cells from apoptotic stimuli, a function that is crucial in 
tumorigenesis, and its insinuation into signal transduction pathways also affords it mechanisms for a 
direct role in cell proliferation. Expression of Orf B alone is sufficient for transformation of cells in 
vitro. rv-cyclin and Orf B probably work together to cause the rapid and efficient formation of dermal 
sarcomas (greater than 85% of infected animals in three months post-infection). The Orf C protein is 
expressed in conjunction with the production of infectious virus and the initiation of tumor regression. 
Orf C induces apoptosis in vitro, and Orf C is present in regressing tumor cells when apoptosis is 
apparent  and  virus  expression  is  greatly  increased.  Other  mechanisms,  particularly  high  levels  of 
WDSV  UVD,  probably  contribute  to  virus  production  and  to  tumor  cell  death.  The  host  immune 
response  likely  contributes  to  rejection  of  the  tumor  mass  and  subsequent  protection  against  new 
tumors.  
The virus and host have established a fine balance in order to orchestrate this seasonal process, thus 
there is little selective pressure on the virus, as is apparent from the stability of its genome over time. 
The significance of this aspect of the model is that viral mechanisms that manipulate the host cell are 
highly refined and their targets are evolutionarily conserved. WDSV must be responsive to certain host 
restriction factors that block infection or replication and yet it must control restriction factors in the 
target tissue during infection, tumor growth, and virus replication. Whether it be restriction factors, 
signal transduction pathways, transcription and splicing regulation, or apoptosis induction, WDSV has 
evolved  a  great  deal  of  control  from  a  very  small  coding  capacity  and  it  leaves  behind  a  fit  and 
reproductive host. 
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